Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Clinical trial NCT00486083 · COMPLETED

Trial details

NCT number: NCT00486083
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2003-12-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.